
Novo Nordisk Invests $1.09 Billion in Brazil
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
CHEManager International is the premier brand for the chemical, pharmaceutical, and biotech industries. It empowers managers and executives with a competitive edge through timely business news, expert insights, and the latest market data, enabling strategic business and investment decisions.
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
The CHEManager Innovation Pitch is both a showcase and a competition for start-ups in the chemical industry. Each year, industry experts select a winning start-up from the finalists.
Abu Dhabi National Oil Company (ADNOC) has launched XRG, an international lower-carbon energy and chemicals investment company, with an enterprise value of over $80 billion.
US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.
Samsung Biologics, a global contract development and manufacturing organization (CDMO), recently announced a series of manufacturing deals with a Europe-based pharmaceutical company.